Naoki Harada
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 18, 2020
Correction to: Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation.Yoriko Yamashita-Kashima, Sei Shu, Masahiro Osada
|Sep 30, 2020
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation.Yoriko Yamashita-Kashima, Sei Shu, Masahiro Osada
|Aug 25, 2020
Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against <i>RET</i>-fusion-positive non-small cell lung cancer cells.Takaaki Fujimura, Koh Furugaki, Naoki Harada
|Jan 20, 2019
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.Yoriko Yamashita-Kashima, Yasushi Yoshimura, Takaaki Fujimura
Pageof 1
